AzTrials
AzTrials

Lower Limb AmputationSTRAALNCT05420623

Walking Strategies in Usual Locomotion of Lower Limb Amputees

An observational study of Lower Limb Amputation, run by FondationbHopale at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Amputation is a life-altering event with an immediate and obvious effect on daily life activities and quality of life. Asymmetrical movements of the lower limbs and compensatory strategies during walking are associated with an elevated risk for developing deleterious secondary health conditions. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Lower Limb Amputation
How many people
80 participants
Where
1 siteFrance
Study dates
16 Dec 2021to 16 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Visits are carried out as part of routine care, either in the case of a follow-up consultation, or as part of a scheduled entry into a rehabilitation center. If the patient is included at the entrance of a scheduled rehabilitation stay, the data from his last follow-up consultation will be recovered retrospectively (follow-up AQM + functional tests). Recruitment of healthy volunteers : The study will be offered to the companions of people followed in rehabilitation at the Jacques Calvé center. Posters will be placed at the reception desk of the institution and in the consultation waiting rooms.

Who may be able to join

  • Major amputation of the lower limb,
  • Unilateral amputation,
  • Aged 18 or over,
  • Mobility level equal to or greater than 2 (according to Medicare Functional Classification Levels),
  • Subject who has given his or her free and informed consent.
  • Non-inclusion Criteria (Amputees patients):
Show all 20Show fewer
  • Definitive apparatus less than one month old,
  • Contraindications for walking,
  • Presence of a major neurocognitive disorder reported in the medical record (as mentioned in the DMS-5): acquired, significant and progressive reduction in abilities in one or more cognitive domains, significant enough to no longer be able to perform activities of daily living alone (loss of autonomy)
  • Cognitive disorders reported in the medical file,
  • Subject under guardianship, curatorship or protective measure,
  • Pregnant or lactating woman.
  • Able to walk 50m alone.
  • Non- Inclusion Criteria (Healthy volunteers):
  • Contraindication to effort,
  • Cognitive disorders known by the subject, causing difficulties in performing tasks related to activities of daily living
  • Any history of neurological or orthopedic origin likely to limit the quality of walking,
  • Notion of trauma on the musculoskeletal system less than 3 months (sprain type, muscle injury, etc.),
  • Subject under guardianship, curatorship or protective measure,
  • Pregnant or lactating woman.

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Fondation HOPALE - Centre de rééducation Jacques CALVE

    Berck, Hauts-de-France, 62608

Other trials in France

About this study

Official title: Determination and Evolution of Usual Locomotion Strategies of Lower Limb Amputees by Gait Analysis

Amputation is a life-altering event with an immediate and obvious effect on daily life activities and quality of life. Asymmetrical movements of the lower limbs and compensatory strategies during walking are associated with an elevated risk for developing deleterious secondary health conditions. It is well established that therapeutic gait training methods are effective in reducing spatiotemporal gait deviations and improving functional mobility. However, the littérature does not clearly indicate the best time to perform a gait training or which gait parameters predict it.

The main aim of this study is to determinate the walking strategies of lower limb amputees in several locomotion tasks on daily life. Then, the investigators study the evolution of these walking strategies after a gait training and over time.

Read the detailed description

Quantified gait analyses are included in the practice for consultations to monitor orthopaedic devices, and are specific to the study for the rehabilitation stay (V2 and V3).

The subjects in the control group will be recruited from among the carers of patients undergoing rehabilitation and from among volunteers recruited by means of posters in the establishments of the HOPALE Foundation in Berck.

Once the eligibility criteria have been checked, a quantified gait analysis and functional tests will be carried out: the 6-minute walk test (T6M) and the Time Up and Go test (TUG). They will complete a single visit lasting approximately 1 hour and 30 minutes.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT05420623
Study groupRoleWhat they receive
Amputees patientsNot described
control group: non-amputeesNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Data from the quantified gait assessment: walking speed (m/s)

    Full body motion capture was systematically analyzed for different walking conditions

    • normal and fast walking on self selected walking speed, walking on cross-slope, go up and down a step, and turn.

    Measured: Inclusion

  2. Data from the quantified gait assessment: step length (m)

    Full body motion capture was systematically analyzed for different walking conditions

    • normal and fast walking on self selected walking speed, walking on cross-slope, go up and down a step, and turn.

    Measured: Inclusion

  3. Data from the quantified gait assessment: step time (s)

    Full body motion capture was systematically analyzed for different walking conditions

    • normal and fast walking on self selected walking speed, walking on cross-slope, go up and down a step, and turn.

    Measured: Inclusion

  4. Data from the quantified gait assessment: lower limbs joint angles (degrees)

    Full body motion capture was systematically analyzed for different walking conditions

    • normal and fast walking on self selected walking speed, walking on cross-slope, go up and down a step, and turn.

    Measured: Inclusion

  5. Data from the quantified gait assessment: joint moments (N.m/kg)

    Full body motion capture was systematically analyzed for different walking conditions

    • normal and fast walking on self selected walking speed, walking on cross-slope, go up and down a step, and turn.

    Measured: Inclusion

  6. Data from the quantified gait assessment: trunk and pelvis position (degrees)

    Full body motion capture was systematically analyzed for different walking conditions

    • normal and fast walking on self selected walking speed, walking on cross-slope, go up and down a step, and turn.

    Measured: Inclusion

  7. Data from the quantified gait assessment: ground reaction forces (N).

    Full body motion capture was systematically analyzed for different walking conditions

    • normal and fast walking on self selected walking speed, walking on cross-slope, go up and down a step, and turn.

    Measured: Inclusion

Secondary outcomes (11)
  1. The correlations between some data from clinical assessment and gait parameters are analyzed : pain scale (Numerical Rating Scale)

    Measured: Inclusion

  2. The correlations between some data from clinical assessment and gait parameters are analyzed : strenght testing of hip abductor/extensor/flexor and knee extensor/flexor (if applicable)

    This measurement will be collected with handheld dynamometer (Newton)

    Measured: Inclusion

  3. The correlations between some data from clinical assessment and gait parameters are analyzed : amputation level and etiology, prosthesis characteristics, lower limbs range of motion with manual goniometer (degrees)

    Measured: Inclusion

  4. The correlations between some data from clinical assessment and gait parameters are analyzed : amputation level and etiology, prosthesis characteristics, functional walking tests (timed up and go test - in seconds).

    Measured: Inclusion

  5. The correlations between some data from clinical assessment and gait parameters are analyzed : amputation level and etiology, prosthesis characteristics, functional walking tests (six minute walk test - in meters).

    Measured: Inclusion

  6. These clinical assessment and these gait parameters on the conditions mentioned are analyzed before and after rehabilitation during consultations, and then at 6 months and at 12 months : pain scale (Numerical Rating Scale)

    Measured: Inclusion, 6 months, 12 months

  7. These clinical assessment and these gait parameters on the conditions mentioned are analyzed before and after rehabilitation, and at 6 and 12 months: strenght testing of hip abductor/extensor/flexor and knee extensor/flexor (if applicable)

    This measurement will be collected with handheld dynamometer (Newton)

    Measured: Inclusion, 6 months, 12 months

  8. These clinical assessment and these gait parameters on the conditions mentioned are analyzed before and after rehabilitation during consultations, and then at 6 months and at 12 months : lower limbs range of motion with manual goniometer (degrees)

    Measured: Inclusion, 6 months, 12 months

  9. These clinical assessment and these gait parameters on the conditions mentioned are analyzed before and after rehabilitation during consultations, and then at 6 months and at 12 months : functional walking tests (timed up and go test, in seconds)

    Measured: Inclusion, 6 months, 12 months

  10. The correlations between some data from clinical assessment and gait parameters are analyzed : amputation level and etiology, prosthesis characteristics, functional walking tests (six-minute walk test, in meters).

    Measured: Inclusion, 6 months, 12 months

  11. If you need a walking aid, the investigators compares the force applied to the walking aid, using a force sensor (Newton), with biomechanical compensations.

    Measured: Inclusion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jun 2022
  2. Study start16 Dec 2021
  3. Primary completion16 Dec 2023
  4. Study completion16 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05420623
Sponsor's protocol ID
HOP-RIPH2-21-01
Acronym
STRAAL
Status last verified
Aug 2023
First submitted
13 Dec 2021
Last updated
7 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Lower Limb Amputation, run by FondationbHopale at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 20 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Data from the quantified gait assessment: walking speed (m/s) (time frame: Inclusion). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in